Cargando…
Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report
BACKGROUND: Cystic Fibrosis (CF) is a genetic disease with equal prevalence across sexes. However, women present worse lung function with faster function decline, earlier onset of bacterial colonization, more frequent pulmonary exacerbations (PE), greater bronchial hyper-responsiveness, and higher m...
Autores principales: | Lamas, Adelaida, Máiz, Luis, de Valbuena, Marta Ruiz, González-Casbas, José Manuel, Suárez, Lucrecia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223734/ https://www.ncbi.nlm.nih.gov/pubmed/25344209 http://dx.doi.org/10.1186/1471-2466-14-165 |
Ejemplares similares
-
Retrospective Analysis of the Effectiveness and Reversibility of Long-Acting Contraception Etonogestrel (Implanon(®)) in Common Marmosets (Callithrix jacchus)
por: Roubos, Sandra, et al.
Publicado: (2021) -
Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients
por: Wu, Jianbo, et al.
Publicado: (2018) -
Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria
por: Moeti, Dikonketjo M.P., et al.
Publicado: (2022) -
Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies
por: Bozkanat, Kubra M., et al.
Publicado: (2021) -
Etonogestrel Implant—To Leave or Stay: A Case Series
por: Thew, Margaret
Publicado: (2017)